Telo Genomics Corp (TELO) - Total Liabilities

Latest as of September 2025: CA$633.60K CAD ≈ $458.34K USD

Based on the latest financial reports, Telo Genomics Corp (TELO) has total liabilities worth CA$633.60K CAD (≈ $458.34K USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Telo Genomics Corp (TELO) net asset momentum to track the company's year-over-year net asset growth rate.

Telo Genomics Corp - Total Liabilities Trend (2012–2025)

This chart illustrates how Telo Genomics Corp's total liabilities have evolved over time, based on quarterly financial data. See TELO free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Telo Genomics Corp Competitors by Total Liabilities

The table below lists competitors of Telo Genomics Corp ranked by their total liabilities.

Company Country Total Liabilities
New Zealand Coastal Seafoods Ltd
AU:NZS
Australia AU$2.94 Million
Alvo Minerals Ltd
AU:ALV
Australia AU$471.67K
Pembroke VCT PLC
LSE:PEMB
UK GBX5.47 Million
Harfang Exploration Inc
V:HAR
Canada CA$496.09K
Asiabasemetals Inc
V:ABZ
Canada CA$915.96K
Pinnacle Minerals Ltd
AU:PIM
Australia AU$243.62K
Mlabs Systems Bhd
KLSE:0085
Malaysia RM10.41 Million

Liability Composition Analysis (2012–2025)

This chart breaks down Telo Genomics Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Telo Genomics Corp market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 0.93 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity -23.73 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 1.04 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Telo Genomics Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Telo Genomics Corp (2012–2025)

The table below shows the annual total liabilities of Telo Genomics Corp from 2012 to 2025.

Year Total Liabilities Change
2025-06-30 CA$396.32K
≈ $286.69K
+5.52%
2024-06-30 CA$375.59K
≈ $271.69K
+20.05%
2023-06-30 CA$312.87K
≈ $226.32K
+35.99%
2022-06-30 CA$230.07K
≈ $166.43K
+49.73%
2021-06-30 CA$153.66K
≈ $111.15K
-60.94%
2020-06-30 CA$393.42K
≈ $284.59K
-69.91%
2019-06-30 CA$1.31 Million
≈ $945.84K
+75.85%
2018-06-30 CA$743.53K
≈ $537.86K
-16.10%
2017-06-30 CA$886.25K
≈ $641.10K
+2441.66%
2016-06-30 CA$34.87K
≈ $25.22K
+113.93%
2015-06-30 CA$16.30K
≈ $11.79K
-2.16%
2014-06-30 CA$16.66K
≈ $12.05K
+22.43%
2013-06-30 CA$13.61K
≈ $9.84K
-20.76%
2012-06-30 CA$17.17K
≈ $12.42K
--

About Telo Genomics Corp

V:TELO Canada Diagnostics & Research
Market Cap
$3.27 Million
CA$4.52 Million CAD
Market Cap Rank
#29302 Global
#1376 in Canada
Share Price
CA$0.05
Change (1 day)
-10.00%
52-Week Range
CA$0.04 - CA$0.08
All Time High
CA$5.10
About

Telo Genomics Corp., a molecular diagnostics company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific conditions, primarily in Canada. The company's TeloView platform measures the 3D structure and spatial organization of telomeres to inform on genetic and molecular characteristics that are predictive o… Read more